English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52170207    Online Users :  731
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to: [ Chinese Items ] [ 0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
or enter the first few letters:   

Showing items 474441-474450 of 2348487  (234849 Page(s) Totally)
<< < 47440 47441 47442 47443 47444 47445 47446 47447 47448 47449 > >>
View [10|25|50] records per page

Institution Date Title Author
國立臺灣大學 2010-05 HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma Lin SY, Hsueh CM, Yu SL, Su CC, Shum WY, Yeh KC, Chang GC, Chen JJ
國立臺灣大學 2010-05 HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma Lin, SY; Hsueh, CM; Yu, SL; Su, CC; Shum, WY; Yeh, KC; Chang, GC; Chen, JJ
臺大學術典藏 2020-06-17T03:01:53Z HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma Lin S.-Y.;Hsueh C.-M.;Sung-Liang Yu;Su C.-C.;Shum W.-Y.;Yeh K.-C.;Chang G.-C.;Chen J.J.W.; Lin S.-Y.; Hsueh C.-M.; SUNG-LIANG YU; Su C.-C.; Shum W.-Y.; Yeh K.-C.; Chang G.-C.; Chen J.J.W.
大葉大學 2007-02 HLJ1 is a novel invasion and tumor suppressor. Tsai, Meng-Feng
國立臺灣大學 2016 HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms Chen, C-H; Chang, W-H; Su, K-Y; Ku, W-H; Chang, G-C; Hong, Q-S; Hsiao, Y-J; Chen, H-C; Chen, H-Y; Wu, R.; Yang, P-C; Chen, J. J. W.; Yu, S-L; 俞松良; 蘇剛毅; 楊泮池
臺大學術典藏 2018-09-10T15:35:59Z HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms Chang, W.-H.; Su, K.-Y.; Ku, W.-H.; Chang, G.-C.; Hong, Q.-S.; Hsiao, Y.-J.; Chen, H.-C.; Chen, H.-Y.; Wu, R.; Yang, P.-C.; Chen, J.J.W.; Yu, S.-L.; Chen, C.-H.; SUNG-LIANG YU; KANG-YI SU; 楊泮池et al.
臺大學術典藏 2020-06-30T08:09:59Z HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms Chen C.-H.;Chang W.-H.;Kang-Yi Su;Ku W.-H.;Chang G.-C.;Hong Q.-S.;Hsiao Y.-J.;Chen H.-C.;Chen H.-Y.;Wu R.;Yang P.-C.;Chen J.J.W.;Yu S.-L.; Chen C.-H.; Chang W.-H.; KANG-YI SU; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; Yang P.-C.; Chen J.J.W.; Yu S.-L.
臺大學術典藏 2020-12-02T02:33:18Z HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms Chen C.-H.; Chang W.-H.; Su K.-Y.; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; Pan-Chyr Yang; Chen J.J.W.; Yu S.-L.; Chen C.-H.; PAN-CHYR YANG et al.
中山醫學大學 2010 HLJ1為新的caspase-3受質且其表現量可以促進非小細胞肺癌因UV所引起之細胞凋亡 林聖怡
臺北市立大學 2010-08-27 HLM多層次線性分析:理論、方法與實務 謝俊義

Showing items 474441-474450 of 2348487  (234849 Page(s) Totally)
<< < 47440 47441 47442 47443 47444 47445 47446 47447 47448 47449 > >>
View [10|25|50] records per page